BioBeat connects entrepreneurs with the leaders in biotech
Get involved and grow a strong business
How can joining up science and value in cell and gene therapy deliver global health impact? The summit will explore the journey from science to patients and what value means for different people and organisations.
GSK and Stevenage Bioscience Catalyst are delighted to host BioBeat19: Accelerating Cell and Gene Therapy, 13.00-18.00, Tuesday 19 November 2019.
Register today: http://www.biobeat19.org
Find out about the trailblazers in biotech:
50 Movers and Shakers in BioBusiness 2019
Here are the biotech leaders to watch. 50 Movers and Shakers in BioBusiness 2018 identifies 50 outstanding women who are revolutionising bioscience products for healthcare from the lab and the clinic to the boardroom, world of finance and ecosystem.
How do we step up biotech partnering to make greater impact on health and wealth? The Francis Crick Institute was delighted to host BioBeat17: Re-shaping biotech partnering on 16 November 2017. This half day event for scientists, entrepreneurs and investors explored strategies and opportunities for successful translation between academia and biotech.
How do we nurture growth in the life science sector and ensure the UK is the best place to develop innovative patient therapies in these turbulent times? These are some of the questions that were discussed at the BioBeat16 summit, on Stretching Biotech Pharma Entrepreneurship, held on 16th November 2016 in Cambridge. Read Miranda’s blog.
The 50 Movers and Shakers in BioBusiness 2015 report really shows how the biotech industry is embracing change, with nearly double the number of Rising Stars compared to last year. 50 outstanding women bioentrepreneurs and business leaders are recognized for their contributions to global health innovation.
2014 saw the expansion of the BioBeat programme with the launch of the 50 Movers and Shakers in BioBusiness 2014 report. Leading in a Collaborative World was the topic at the annual autumn event in Cambridge. There were discussions about leading in a rapidly changing sector, multi‐disciplinary working and attitudes to risk in a world where organisations must manage the tension between collaboration and competition.
An international line up of speakers kicked off the BioBeat programme, sharing their knowledge about growing biobusinesses. There were debates on responding to global healthcare challenges, building companies in new markets, essentials to secure funding and creating effective teams and boards